0
Editorials |

Telesupport : Just Reach Out and Touch Someone

Steven D. Nathan, MD; Scott D. Barnett, PhD
Author and Funding Information

Affiliations: Falls Church, VA
 ,  Drs. Nathan and Barnett are affiliated with Inova Fairfax Hospital.

Correspondence to: Steven Nathan, MD, Inova Fairfax Hospital, 3300 Gallows Rd, Falls Church, VA 22042-3300; e-mail: steven.nathan@inova.com



Chest. 2002;122(4):1114-1116. doi:10.1378/chest.122.4.1114
Text Size: A A A
Published online

Extract

Lung transplantation is an accepted therapeutic option for patients who have a number of end-stage pulmonary diseases. In calendar year 1999, the United Network for Organ Sharing reported1 that 877 lung transplants and 49 heart-lung transplants had been performed in the United States alone, with a waiting list of 3,491 persons. During the same time period, > 2,000 transplants were performed worldwide.2 About 76% of lung transplant recipients will survive through the first year, and 56% make it to 3 years.1 When assessing the efficacy of a given intervention on outcomes for any end-stage organ disease, there is a growing emphasis not only on improvements in survival, but also on the associated health-related quality of life (HRQOL). Incorporating HRQOL and survival has resulted in the generation of quality-adjusted life years (QALY) as a measure of transplantation outcomes.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543